Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis

Wenjia Yang; Xiaoling Cai; Xueying Gao; Yifei Chen; Ling Chen; Linong Ji

doi:10.1111/jdi.12764

Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis

Journal of Diabetes Investigation ◽

10.1111/jdi.12764 ◽

2017 ◽

Vol 9 (4) ◽

pp. 813-821 ◽

Cited By ~ 12

Author(s):

Wenjia Yang ◽

Xiaoling Cai ◽

Xueying Gao ◽

Yifei Chen ◽

Ling Chen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Treatment ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Effect of dipeptidyl peptidase 4 inhibitors on cardiovascular events in type-2 diabetes patients with renal impairment: A systematic review and meta-analysis

Indian Journal of Endocrinology and Metabolism ◽

10.4103/ijem.ijem_568_19 ◽

2020 ◽

Vol 24 (2) ◽

pp. 143

Author(s):

Maneesha Khalse ◽

B Ganapathy

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Renal Impairment ◽

Cardiovascular Events ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Effect of Dipeptidyl Peptidase 4 Inhibitors Used in Combination with Insulin Treatment in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis

Diabetes Therapy ◽

10.1007/s13300-020-00914-x ◽

2020 ◽

Vol 11 (10) ◽

pp. 2371-2382

Author(s):

Jin Yang ◽

Qing Tian ◽

Yuexin Tang ◽

Arvind K. Shah ◽

Ruya Zhang ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Treatment ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Efficacy and safety of dipeptidyl peptidase-4 inhibitors as an add-on to insulin treatment in patients with Type 2 diabetes: a review

Diabetic Medicine ◽

10.1111/dme.12561 ◽

2014 ◽

Vol 31 (11) ◽

pp. 1293-1300 ◽

Cited By ~ 12

Author(s):

C. S. S. Frandsen ◽

S. Madsbad

Keyword(s):

Type 2 Diabetes ◽

Insulin Treatment ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase‐4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2058 ◽

2020 ◽

Author(s):

Chen‐Yi Yang ◽

Wei‐Ann Lin ◽

Pei‐Fang Su ◽

Lun‐Jie Li ◽

Chun‐Ting Yang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Diseases ◽

Treatment Effects ◽

Dipeptidyl Peptidase ◽

Heterogeneous Treatment Effects ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Review for "Lower Cardiorenal Risk with Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study"

10.1111/dom.14189/v2/review4 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Dipeptidyl Peptidase ◽

Renal Diseases ◽

Dipeptidyl Peptidase 4 ◽

Sodium Glucose Cotransporter ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Decision letter for "Lower Cardiorenal Risk with Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study"

10.1111/dom.14189/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Dipeptidyl Peptidase ◽

Renal Diseases ◽

Dipeptidyl Peptidase 4 ◽

Sodium Glucose Cotransporter ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Dipeptidyl Peptidase 4 Inhibitors and Venous Thromboembolism Risk in Patients with Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials

Thrombosis and Haemostasis ◽

10.1055/s-0040-1715444 ◽

2020 ◽

Author(s):

Li Xin ◽

Shusen Sun ◽

Jinwen Wang ◽

Wenchao Lu ◽

Tiansheng Wang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Venous Thromboembolism ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Cardiovascular Outcomes ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

BMJ ◽

10.1136/bmj.i610 ◽

2016 ◽

pp. i610 ◽

Cited By ~ 123

Author(s):

Ling Li ◽

Sheyu Li ◽

Ke Deng ◽

Jiali Liu ◽

Per Olav Vandvik ◽

...

Keyword(s):

Heart Failure ◽

Systematic Review ◽

Type 2 Diabetes ◽

Observational Studies ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Author Correction: Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials

Scientific Reports ◽

10.1038/s41598-017-16510-2 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 2

Author(s):

Ming Zhao ◽

Jiayi Chen ◽

Yanyan Yuan ◽

Zuquan Zou ◽

Xiaolong Lai ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trials ◽

Cancer Risk ◽

Randomized Clinical Trials ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2012.01603.x ◽

2012 ◽

Vol 14 (8) ◽

pp. 762-767 ◽

Cited By ~ 125

Author(s):

C. F. Deacon ◽

E. Mannucci ◽

B. Ahrén

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text